Advertisement
Canada markets closed

  • S&P/TSX

    22,011.72
    +139.76 (+0.64%)
     

  • S&P 500

    5,070.55
    +59.95 (+1.20%)
     

  • DOW

    38,503.69
    +263.71 (+0.69%)
     

  • CAD/USD

    0.7320
    +0.0000 (+0.00%)
     

  • CRUDE OIL

    83.43
    +0.07 (+0.08%)
     

  • Bitcoin CAD

    90,843.52
    -434.18 (-0.48%)
     

  • CMC Crypto 200

    1,433.50
    +18.74 (+1.33%)
     

  • GOLD FUTURES

    2,335.90
    -6.20 (-0.26%)
     

  • RUSSELL 2000

    2,002.64
    +35.17 (+1.79%)
     

  • 10-Yr Bond

    4.5980
    -0.0250 (-0.54%)
     

  • NASDAQ futures

    17,696.25
    +89.50 (+0.51%)
     

  • VOLATILITY

    15.69
    -1.25 (-7.38%)
     

  • FTSE

    8,044.81
    +20.94 (+0.26%)
     

  • NIKKEI 225

    38,049.16
    +497.00 (+1.32%)
     

  • CAD/EUR

    0.6837
    +0.0001 (+0.01%)
     

Vaccine Contract Manufacturing Market Forecast 2020-2030

ReportLinker
·3 min read

Prospects for Attenuated Vaccine, Inactivated Vaccine, Fluoroquinolones, Subunit Vaccines, Toxoid Vaccines. The global vaccine contract manufacturing market was worth $2,241. 6m in 2019 and is expected to grow at a CAGR of 9.

New York, April 13, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Vaccine Contract Manufacturing Market Forecast 2020-2030" - https://www.reportlinker.com/p06058572/?utm_source=GNW
3% from 2020-2025.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 290-page report you will receive 89 tables and 105 figures– all unavailable elsewhere.

The 290-page report provides clear detailed insight into the global vaccine contract manufacturing market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand new report today you stay better informed and ready to act.

Report Scope

• Revenue and growth forecasts from 2020 to 2030 for the global vaccine market

• Revenue and growth forecasts from 2020 to 2030 for the global vaccine contract manufacturing market

• Revenue and growth forecasts from 2020 to 2030 for the global vaccine contract manufacturing market by type:
• Attenuated Vaccines
• Inactivated Vaccines
• Fluoroquinolones
• Subunit Vaccines
• Toxoid Vaccines

• Revenue and growth forecasts from 2020 to 2030 for the global vaccine contract manufacturing market by workflow:
• Downstream Processing: the revenues are further broken down into Fill & Finish Operations, Analytical & QC Studies, Packaging
• Upstream Processing: the revenues are further broken down into Mammalian Expression Systems, Bacterial Expression Systems, Yeast Expression Systems, Baculovirus/Insect Expression Systems, Other Upstream Processing

• Revenue and growth forecasts from 2020 to 2030 for the leading regional and national markets:
• North America: the revenues are further broken down into the US and Canada
• Europe: the revenues are further broken down into the UK, Germany, France, Italy and Spain
• Asia-Pacific: the revenues are further broken down into China, Japan, India and Rest of Asia-Pacific
• Latin America: the revenues are further broken down into Brazil, Mexico, and Rest of Latin America
• Middle East & Africa: the revenues are further broken into Saudi Arabia, South Africa and Rest of Middle East & Africa

The regional markets are further broken down by type and workflow.

• Discussion and profiles of the leading players in the vaccine contract manufacturing market:
• AbbVie
• Baxter BioPharma Solutions
• Boehringer Ingelheim
• Catalent
• Charles River Laboratories
• IDT Biologika
• Lonza
• Meridan Lifescience
• Pfizer
• And many more

• A SWOT analysis discussing the industry trends, strengths, weaknesses, opportunities and threats.

• Discussion on vaccine manufacturing technologies covering new substrates for vaccine production, next-generation expression systems and vectors, equipment trends, pre-filled syringes and vaccines, lyophilization and vaccine manufacturing, cell-based techniques.

• Key Questions Answered by this Report:
• How is the vaccine contract manufacturing market evolving?
• What is driving and restraining the vaccine contract manufacturing market?
• What are the market shares of the leading segments of the vaccine contract manufacturing market in 2019?
• What is the value of the leading sectors in important regions of the world?
• What will be the main driver of the overall market from 2020 to 2030?
• How will political and regulatory factors influence the regional markets and submarkets?
• Will leading national vaccine contract manufacturing markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
• How will the market shares of the leading national markets change by 2030 and which country will lead the market in 2030?
• How will the industry evolve during the period between 2020 and 2030?

This study is intended for anyone requiring commercial analyses for the global vaccine contract manufacturing market. You find data, trends and predictions.
Read the full report: https://www.reportlinker.com/p06058572/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001